Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina.
Guillain-Barré syndrome: What have we learnt during one century? A personal historical perspective.
Cadm3 (Necl-1) interferes with the activation of the PI3 kinase/Akt signaling cascade and inhibits Schwann cell myelination in vitro.
Poster 487 Chronic Inflammatory Demyelinating Polyneuropathy or Something Else?: A Case Report.
Protein C receptor (PROCR) is a negative regulator of Th17 pathogenicity.
G Protein-Coupled Receptors in Myelinating Glia.
Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP).
A cord blood monocyte-derived cell therapy product accelerates brain remyelination.
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Treatment of the osmotic demyelination syndrome: the earlier the better?
The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica.
Down-regulation of CYP27B1 gene expression in Iranian patients with relapsing-remitting multiple sclerosis.
Blink reflex role in algorithmic genetic testing of inherited polyneuropathies.
Autoimmunity meets genetics: Multiple sclerosis in a patient with Kallmann syndrome.
No evidence for increased brain iron deposition in patients with ischemic white matter disease.
Adipose-Derived Stem Cells Enhance Axonal Regeneration through Cross-Facial Nerve Grafting in a Rat Model of Facial Paralysis.
Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis.
Identification of gene expression patterns critically involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.
Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
Multiple sclerosis: Successful trial of amiselimod for multiple sclerosis.
Chronic iron overload induces gender-dependent changes in iron homeostasis, lipid peroxidation and clinical course of experimental autoimmune encephalomyelitis.
Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.
Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
Pages
« first
‹ previous
…
833
834
835
836
837
838
839
840
841
…
next ›
last »